NBSE — NeuBase Therapeutics Share News
0.000.00%
Last trade - 00:00Brief: NeuBase Therapeutics Received Letter From The Nasdaq Stock Market Notifying Notice Of Delisting
U.S. RESEARCH ROUNDUP-Goodrx Holdings, Nextnav, Olo
Brief: NeuBase Therapeutics Reports Business Update And Results For Q3 Of FY2022
NeuBase Therapeutics Inc reports results for the quarter ended in June - Earnings Summary
NeuBase Therapeutics Inc expected to post a loss of 30 cents a share - Earnings Preview
Brief: NeuBase Therapeutics Announces Promotion Of Dr. William Mann To President And COO
NeuBase Therapeutics Inc reports results for the quarter ended in March - Earnings Summary
Brief: NeuBase Therapeutics Reports Results For The Second Quarter Of Fiscal Year 2022
NeuBase Therapeutics Inc expected to post a loss of 23 cents a share - Earnings Preview
Brief: Neubase Therapeutics Reports Q1 Loss Per Share Of $0.24
NeuBase Therapeutics Inc expected to post a loss of 23 cents a share - Earnings Preview
U.S. STOCKS ON THE MOVE-Netflix, streaming cos, OceanPal, crypto stocks
NeuBase Therapeutics Inc reports results for the quarter ended in September - Earnings Summary
Brief: Neubase Therapeutics Reports Business Update And Financial Results For Fiscal Year 2021
NeuBase Therapeutics Inc expected to post a loss of 23 cents a share - Earnings Preview
Brief: VBL Therapeutics Announces Appointment Of Sam Backenroth As CFO And Establishes Operations In The United States
Brief: NeuBase Therapeutics Inc Entered Into An Open Market Sale Agreement With Jefferies Llc
U.S. RESEARCH ROUNDUP-Adobe, Goodrx Holdings, PG&E
NeuBase Therapeutics Inc expected to post a loss of 21 cents a share - Earnings Preview